Institutional Ownership
Sutro Biopharma Inc
CUSIP 869367201COM SHSSTROQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
8.8%
Max % of class reported
Institutional Holders
68
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 18, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bvf Inc/Il | 1.25M | $31.18M |
| 2 | Affinity Asset Advisors, LLC | 1.07M | $26.64M |
| 3 | Samsara Biocapital, LLC | 1.06M | $26.48M |
| 4 | Kynam Capital Management, LP | 872.6K | $21.74M |
| 5 | Orbimed Advisors LLC | 801.1K | $19.96M |
| 6 | Perceptive Advisors LLC | 715.3K | $17.82M |
| 7 | Ra Capital Management, L.P. | 715.3K | $17.82M |
| 8 | Eventide Asset Management, LLC | 715.3K | $17.82M |
| 9 | Point72 Asset Management, L.P. | 692.1K | $17.24M |
| 10 | Adar1 Capital Management, LLC | 524.4K | $13.06M |